Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Premier Biomedical Inc
BIEI | US
0.00
USD-0.00
-20.00%
BIEI | US
About Premier Biomedical Inc
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
30/06/2024
As of date
06/03/2026
Close
0.00
Open
0.00
High
0.00
Low
0.00
Premier Biomedical Inc. a research-based company discovers and develops medical products for the treatment of PTSD cancer and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products including anti-pain patch roll-on topical products sprays ointments tincture drop product a hemp oil capsule and pet product; sequential-dialysis technique for cancer Alzheimer's disease ALS blood sepsis leukemia and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis fibromyalgia neuropathic pain and traumatic brain injuries. Premier Biomedical Inc. was founded in 2010 and is headquartered in Jackson Center Pennsylvania.
View LessBIEI | US
Risk
200.8
Sharpe
-0.13
Luna's Score
33/100
Recommendation
Sell
Luna says (BIEI | US)
What's Working
Low Debt to Equity (< 0.25)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
271.2%1 month
200.8%3 months
342.7%6 months
271.1%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
-
Debt to equity
-0.23
Debt to assets
181.35
Ent. to EBITDA
76.52
Ent. to rev.
112.03
PEG
-
Other Fundamentals
EBITDA
-323.90K
MarketCap
439.55K
MarketCap(USD)
439.55K
Div. yield
-
Op. margin
-8.20K
Erngs. growth
-
Rev. growth
-85.60
Ret. on equity
-
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.00
Range1M
0.00
Range3M
0.00
Volumes: Market Activity
Rel. volume
0.16
Price X volume
472.00
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 76.52 | 24.85 | Expensive |
| Ent. to Revenue | 112.03 | 361.91 | Cheaper |
| PE Ratio | - | 30.05 | - |
| Price to Book | - | 13.15 | - |
| Dividend Yield | - | 2.94 | - |
| Std. Deviation (3M) | 342.69 | 65.24 | Riskier |
| Debt to Equity | -0.23 | -1.88 | Expensive |
| Debt to Assets | 181.35 | 0.48 | Expensive |
| Market Cap | 439.55K | 3.71B | Emerging |
